DCF — THE NEBRASKA MEDICAL CENTER
Enterprise Value: $-1.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.3B
Enterprise Value
$-421.2M
PV of Cash Flows
$-837.9M
PV of Terminal Value
$-1.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.5B | $-66.0M | -4.0% | $-128.1M | $-116.4M |
| Year 2 | $1.5B | $-52.9M | -3.0% | $-116.8M | $-96.5M |
| Year 3 | $1.6B | $-38.9M | -2.0% | $-104.7M | $-78.7M |
| Year 4 | $1.6B | $-32.0M | -2.0% | $-99.9M | $-68.2M |
| Year 5 | $1.7B | $-28.9M | -2.0% | $-98.7M | $-61.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999971902979
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5